Signaling Pathways - LPA - Raf - PTP - Insulin and Insulin-like Receptors
清除全部
- B7818 ONO-7300243Target: LPASummary: LPA1拮抗剂
- A8716 LY3009120Target: RafSummary: Pan-RAF和RAF二聚体抑制剂
- B1174 LGX818中文名: 康奈非尼Target: RafSummary: RAF抑制剂
- B1407 Dabrafenib (GSK2118436)3 Citation中文名: 达拉菲尼Target: RafSummary: BRAF(V600)突变抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A8313 RAF265Target: Raf|VEGFRSummary: 多细胞激酶抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A5071 GDC-08791 CitationTarget: RafSummary: B-Raf抑制剂
- A8245 Sorafenib Tosylate1 Citation中文名: 甲苯磺酸索拉非尼Target: Raf|VEGFRSummary: Raf激酶和酪氨酸激酶抑制剂